Zenicor Medical Systems AB
Research Zenicor Medical Systems AB (ZENI) on Bullrun: valuation model: 12.3% undervalued, market cap SEK 25.95M, P/E 14.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZENI
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Valuation signal12.3% undervalued
- Market capSEK 25.95M
- P/E14.1
- Financial periodQ4 2025
- RevenueSEK 8.11M
- Net incomeSEK 1.21M
- Free cash flow-SEK 4.89M
- Gross margin97.8%
Valuation Snapshot
Bullrun's latest valuation model marks Zenicor Medical Systems AB as 12.3% undervalued; latest market cap is SEK 25.95M; P/E is 14.1.
About Zenicor Medical Systems AB
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection; and Zenicor View, a web-based system solution for all types of arrhythmia investigations. It also provides Zenicor Direct, a solution with interpretation services and services for device logistics.
Frequently asked questions
Is Zenicor Medical Systems AB overvalued or undervalued?
Bullrun's valuation model currently marks Zenicor Medical Systems AB as 12.3% undervalued.
What is Zenicor Medical Systems AB's market cap?
Zenicor Medical Systems AB's market capitalization is SEK 25.95M.
What is Zenicor Medical Systems AB's P/E ratio?
Zenicor Medical Systems AB's price-to-earnings (P/E) ratio is 14.1.
What does Zenicor Medical Systems AB do?
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection;